CA2457863A1 - Procedes de preparation de derives du glycopeptide phosphonate - Google Patents

Procedes de preparation de derives du glycopeptide phosphonate Download PDF

Info

Publication number
CA2457863A1
CA2457863A1 CA002457863A CA2457863A CA2457863A1 CA 2457863 A1 CA2457863 A1 CA 2457863A1 CA 002457863 A CA002457863 A CA 002457863A CA 2457863 A CA2457863 A CA 2457863A CA 2457863 A1 CA2457863 A1 CA 2457863A1
Authority
CA
Canada
Prior art keywords
process according
group
formula
compound
amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002457863A
Other languages
English (en)
Other versions
CA2457863C (fr
Inventor
Michael Leadbetter
Martin Linsell
Junning Lee
Jyanwei Liu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cumberland Pharmaceuticals Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2457863A1 publication Critical patent/CA2457863A1/fr
Application granted granted Critical
Publication of CA2457863C publication Critical patent/CA2457863C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA2457863A 2001-08-24 2002-08-23 Procedes de preparation de derives du glycopeptide phosphonate Expired - Fee Related CA2457863C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31483101P 2001-08-24 2001-08-24
US60/314,831 2001-08-24
PCT/US2002/026853 WO2003029270A2 (fr) 2001-08-24 2002-08-23 Procedes de preparation de derives du glycopeptide phosphonate

Publications (2)

Publication Number Publication Date
CA2457863A1 true CA2457863A1 (fr) 2003-04-10
CA2457863C CA2457863C (fr) 2012-01-03

Family

ID=23221639

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2457863A Expired - Fee Related CA2457863C (fr) 2001-08-24 2002-08-23 Procedes de preparation de derives du glycopeptide phosphonate

Country Status (15)

Country Link
US (5) US6979723B2 (fr)
EP (1) EP1418933B1 (fr)
JP (2) JP4116555B2 (fr)
KR (1) KR100909438B1 (fr)
CN (1) CN1246036C (fr)
AT (1) ATE361312T1 (fr)
AU (1) AU2002326739B2 (fr)
BR (1) BRPI0211997B8 (fr)
CA (1) CA2457863C (fr)
DE (1) DE60219927T2 (fr)
DK (1) DK1418933T3 (fr)
ES (1) ES2286274T3 (fr)
NO (1) NO331661B1 (fr)
TW (1) TWI275594B (fr)
WO (1) WO2003029270A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA75083C2 (uk) 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
TWI275594B (en) * 2001-08-24 2007-03-11 Theravance Inc Process for preparing vancomycin phosphonate derivatives
WO2003106399A2 (fr) 2002-06-17 2003-12-24 Theravance, Inc. Procede de preparation de composes aldehydes $g(b)-amino <i>n</i>-proteges
TWI342312B (en) * 2003-10-22 2011-05-21 Theravance Inc Hydrochloride salts of a glycopeptide phosphonate derivative
WO2013034675A1 (fr) 2011-09-09 2013-03-14 Sandoz Ag Procédé de synthèse de télavancine et de ses sels pharmaceutiquement acceptables et dérivés n-protégés correspondants
WO2013034676A1 (fr) 2011-09-09 2013-03-14 Sandoz Ag Procédé de synthèse de télavancine et de ses sels pharmaceutiquement acceptables et dérivé imine n-protégé de télavancine
MX2015011760A (es) 2013-03-15 2016-06-10 Melinta Therapeutics Inc Metodos para tratar infecciones en pacientes obesos y con sobrepeso usando antibioticos.
WO2016063246A1 (fr) * 2014-10-22 2016-04-28 Sun Pharmaceutical Industries Limited Forme cristalline r de phosphate de tédizolide
WO2016137806A2 (fr) 2015-02-23 2016-09-01 Theravance Biopharma Antibiotics Ip, Llc Doses et procédés d'administration de télavancine
CN106467570B (zh) * 2015-08-14 2020-04-07 正大天晴药业集团股份有限公司 糖肽类抗生素的还原烷基化方法
CN106631902A (zh) * 2016-09-23 2017-05-10 上海步越化工科技有限公司 一种特拉万星侧链癸基(2‑氧代乙基)氨基甲酸9h‑芴‑9‑甲基酯的制备方法
CN107629116B (zh) * 2017-09-08 2021-05-07 福建省微生物研究所 一种特拉万星的纯化方法
CN107629115B (zh) * 2017-09-08 2021-05-07 福建省微生物研究所 一种特拉万星的纯化方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3160632A (en) * 1961-01-30 1964-12-08 Stauffer Chemical Co Aminomethylenephosphinic acids, salts thereof, and process for their production
US4643967A (en) * 1983-07-07 1987-02-17 Bryant Bernard J Antibody method for lowering risk of susceptibility to HLA-associated diseases in future human generations
US4698327A (en) 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
IL78597A0 (en) 1985-04-25 1986-08-31 Lilly Co Eli Novel glycopeptide derivatives
US4643987A (en) 1985-08-14 1987-02-17 Eli Lilly And Company Modified glycopeptides
DE68925806T2 (de) 1988-12-27 1996-09-26 Lepetit Spa C63-Amidderivate von 34-de(acetylglucosaminyl)-34-deoxy-teicoplaninen
NZ236393A (en) 1989-12-13 1992-05-26 Lilly Co Eli N-alkylated glycopeptide derivatives prepared from antibiotics a82846 series and pa-42867-a; pharmaceutical compositions
RU2125058C1 (ru) 1991-07-29 1999-01-20 Группо Лепетит С.П.А. Производное антибиотика а 40926, способы его получения, фармацевтическая композиция
US5750509A (en) 1991-07-29 1998-05-12 Gruppo Lepetit S.P.A. Amide derivatives of antibiotic A 40926
MY128335A (en) 1994-01-28 2007-01-31 Lilly Co Eli Glycopeptide antibiotic derivatives
US5840684A (en) 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
US5561714A (en) * 1994-12-12 1996-10-01 Tektronix, Inc. Scrambling system for serial digital video
US5919756A (en) 1996-06-28 1999-07-06 Eli Lilly And Company Amides
US5939382A (en) 1996-11-21 1999-08-17 Eli Lilly And Company Reducing agent for reductive alkylation of glycopeptide antibiotics
US5952466A (en) 1997-11-12 1999-09-14 Eli Lilly And Company Reductive alkylation of glycopeptide antibiotics
US5916873A (en) 1997-04-17 1999-06-29 Eli Lilly And Company Teicoplanin derivatives
US6518242B1 (en) 1998-02-20 2003-02-11 Theravance, Inc. Derivatives of glycopeptide antibacterial agents
CA2318394A1 (fr) 1998-02-20 1999-08-26 Advanced Medicine, Inc. Nouveaux agents antibacteriens
SI1140993T1 (en) 1998-12-23 2003-12-31 Theravance, Inc. Glycopeptide derivatives and pharmaceutical compositions containing the same
JP2000281694A (ja) * 1999-03-29 2000-10-10 Tanaka Kikinzoku Kogyo Kk 有機金属気相エピタキシー用の有機金属化合物
AU4054900A (en) 1999-04-02 2000-10-23 Advanced Medicine East, Inc. Desleucyl glycopeptide antibiotics and methods of making same
DE60135102D1 (de) 2000-05-02 2008-09-11 Theravance Inc Verfahren zur reduktiven alkylierung von glykopeptiden
AU2001259306A1 (en) * 2000-05-02 2001-11-12 Advanced Medicine, Inc. Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin
AU2001259816A1 (en) * 2000-06-22 2002-01-02 Advanced Medecine, Inc. Polyhydroxy glycopeptide derivatives
UA75083C2 (uk) 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
KR20020013174A (ko) * 2000-08-11 2002-02-20 민경윤 경구 흡수율이 낮은 약물의 흡수율을 증가시키기 위한경구용 조성물
TWI275594B (en) * 2001-08-24 2007-03-11 Theravance Inc Process for preparing vancomycin phosphonate derivatives
US7726104B2 (en) * 2006-06-21 2010-06-01 Cp Packaging, Inc. Vacuum packaging system with end cutter

Also Published As

Publication number Publication date
DE60219927T2 (de) 2008-01-17
US20080227963A1 (en) 2008-09-18
WO2003029270A3 (fr) 2003-09-04
JP4116555B2 (ja) 2008-07-09
NO331661B1 (no) 2012-02-20
US20050020488A1 (en) 2005-01-27
TWI275594B (en) 2007-03-11
US7301004B2 (en) 2007-11-27
US7728104B2 (en) 2010-06-01
US20060264607A1 (en) 2006-11-23
US6979723B2 (en) 2005-12-27
DE60219927D1 (de) 2007-06-14
EP1418933A2 (fr) 2004-05-19
CN1246036C (zh) 2006-03-22
CA2457863C (fr) 2012-01-03
WO2003029270A2 (fr) 2003-04-10
JP2005526000A (ja) 2005-09-02
BR0211997A (pt) 2006-04-04
JP2008208130A (ja) 2008-09-11
ES2286274T3 (es) 2007-12-01
CN1547481A (zh) 2004-11-17
BRPI0211997B8 (pt) 2016-11-16
EP1418933A4 (fr) 2004-10-27
US7074890B2 (en) 2006-07-11
NO20040766L (no) 2004-04-29
US8093354B2 (en) 2012-01-10
ATE361312T1 (de) 2007-05-15
BRPI0211997B1 (pt) 2016-10-11
EP1418933B1 (fr) 2007-05-02
DK1418933T3 (da) 2007-06-11
AU2002326739B2 (en) 2007-10-18
US20030069391A1 (en) 2003-04-10
KR100909438B1 (ko) 2009-07-28
US20110060122A1 (en) 2011-03-10
KR20040028999A (ko) 2004-04-03

Similar Documents

Publication Publication Date Title
CA2457863A1 (fr) Procedes de preparation de derives du glycopeptide phosphonate
NO20062378L (no) Fremgangsmate for fremstilling av hovedsakelig losningsmiddelfrie sma partikler
CA2457215A1 (fr) Processus de preparation de derives de glycopeptide
EP0816378B1 (fr) Dérivés d&#39;amides antibiotiques glycopeptidiques
RU2003101969A (ru) Новые соединения, обладающие антибактериальной, противогрибковой и противоопухолевой активностью
RU2007123235A (ru) Противоопухолевые соединения
YU29502A (sh) Proces dobijanja 4&#34;-supstituisanog 9-dezokso-9a-aza-9a derivata homoeritromicina a
RU92004336A (ru) Водорастворимые производные камптотецина, способ их получения, фармацевтическая композиция, способ ингибирования энзима топоизомеразы, промежуточные продукты
KR870003130A (ko) 테이코플라닌 화합물의 아미드
BG104640A (en) Novel erythromycin derivatives
KR930000481A (ko) 시클릭 이미드 유도체
JP4240544B2 (ja) アルキル化ヘキサペプチド
RU2004106630A (ru) Новые депсипептиды и способы их получения
HU211347A9 (en) Amide derivatives of antibiotic a 40926
NZ533864A (en) Method for preparing echinocandin derivatives and their compositions
WO2008062436A4 (fr) Dérivés antimicrobiens d&#39;acide anacardique et procédé de fabrication de ceux-ci
JP2001524083A (ja) テイコプラニン誘導体
RU94045799A (ru) СПОСОБ ПОЛУЧЕНИЯ β-ФЕНИЛИЗОСЕРИНА И ЕГО АНАЛОГОВ, СПОСОБ ПОЛУЧЕНИЯ ПРОИЗВОДНЫХ ТАКСАНА И ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ СИНТЕЗА
IE64155B1 (en) New substituted alkylamide derivatives of teicoplanin
IL41556A (en) N-carboxyalkyl triiodoisopthalic acid amides process for their manufacture and their use as x-ray shading agents
EP0882721A1 (fr) Acides sialiques 2,7-dideoxy-7-fluoro- 2, 3-didehydro a quadruple substitution
HK1045988B (zh) 製備具有抗肥胖和抗糖尿病性質的芳基乙醇胺衍生物的方法
JPH0832699B2 (ja) キセノクマシン
CA2452920A1 (fr) Derives de benzo [g] quinoline destines au traitement du glaucome et de la myopie
RU2365594C2 (ru) Применение циклических пептидов анабенопептинового типа для лечения состояния, при котором полезно ингибирование карбоксипептидазы u, новые анабенопептиновые производные и их промежуточные соединения

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20200831